Statins and ALS: What does the latest science say? No credible evidence links statins to ALS. Long-term use may even lower risk. Don't stop your statin unless your doctor says so.
Read More
Bempedoic acid helps lower cholesterol for statin-intolerant patients, but carries real risks of gout, tendon rupture, and liver issues. Know the warning signs and how to stay safe.
Read More
Mediterranean, DASH, and plant-forward diets are proven to reduce heart disease risk by lowering blood pressure, cholesterol, and inflammation. Learn how each works, how they compare, and how to start today.
Read More
Drinking water before meals can reduce appetite, lower calorie intake, and boost metabolism-helping you lose weight without dieting. Science shows it works better than diet drinks and has no side effects.
Read More
Benzodiazepine tapering is a safe, evidence-based way to reduce dependence on medications like Xanax and Valium. Learn the science-backed steps, timelines, and support strategies that help people successfully stop without severe withdrawal.
Read More
Cancer combination therapies rely on precise drug interactions - but generic versions may disrupt this balance. Learn why bioequivalence standards fail for multi-drug regimens and what patients and providers need to know.
Read More
Pharmacists should recommend authorized generics for patients with allergies to inactive ingredients, those on narrow therapeutic index drugs, or when consistency matters. They're identical to brand-name drugs but often cheaper-though insurance coverage can vary.
Read More
FDA warning letters are serious enforcement actions against drug manufacturers for CGMP violations. Learn what triggers them, how they impact businesses, and how companies can respond effectively to avoid costly delays and regulatory escalation.
Read More
FDA warning letters are formal notices to drug manufacturers for violating quality standards. They cite specific regulatory failures, demand corrective actions, and are publicly posted. Learn what triggers them, how to respond, and why they’re costing companies millions.
Read More
Diabetes greatly increases heart disease risk, but combining GLP-1 receptor agonists like semaglutide with proven lifestyle changes can slash cardiovascular events by over 60%. Learn how medication and habits work together to protect your heart.
Read More